✦ LIBER ✦

High dose (HD) cytosine arabinoside (ARA-C) for the treatment of minimal residual disease in acute myelogenous leukemia (AML)

✍ Scribed by G.P. Herzig; S.N. Wolff; R.H. Herzig; R.S. Stein; H.M. Lazarus; J.M. Marion; T.R. Sptizer; J.M. Flexner; G.L. Phillips

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of minimal residual disease in

✍ M.J. Barnett; J.E. Kingston; A. Miller; L.K. Goff; T.S. Ganesan; R. Biruls; A.Z. 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 93 KB

High Dose Ara-C Combined with Autologous

✍ Øystein Bruserud; Peter Ernst 📂 Article 📅 2000 🏛 AlphaMed Press 🌐 English ⚖ 34 KB

The role of timing of high-dose cytosine

✍ William G. Woods; Frederick B. Ruymann; Beatrice C. Lampkin; Jonathan D. Buckley 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

Superiority of high-dose over intermedia

✍ Kern, W; Aul, C; Maschmeyer, G; Schönrock-Nabulsi, R; Ludwig, W D; Bartholomäus, 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

High-dose cytosine arabinoside and dauno

✍ Hillard M. Lazarus; W. Ralph Vogler; C. Patrick Burns; Elliott F. Winton 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

High-dose versus intermediate-dose cytos

✍ Hiddemann, Wolfgang; Schleyer, Eberhard; Uhrmeister, Christa; Aul, Carlo H.; Mas 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 472 KB